Author

Niyanta N. Kumar

Observed names: N. Kumar, Niyanta Kumar

Institution: Mersana Therapeutics (United States)

Observed institutions: Merck & Co., Inc., Rahway, NJ, USA (United States), Mayo Clinic, University of Wisconsin–Madison, Mersana Therapeutics (United States)

ORCID: 0000-0003-0302-7850

Observed ORCID: 0000-0003-0302-7850

OpenAlex ID: A5102732165

Intrathecal antibody distribution in the rat brain: surface diffusion, perivascular transport and osmotic enhancement of delivery

2017 · Michelle E. Pizzo, Daniel J. Wolak, et al. · The Journal of Physiology · 277

Delivery of immunoglobulin G antibodies to the rat nervous system following intranasal administration: Distribution, dose-response, and mechanisms of delivery

2018 · Niyanta N. Kumar, Jeffrey J. Lochhead, et al. · Journal of Controlled Release · 95

Relative vascular permeability and vascularity across different regions of the rat nasal mucosa: implications for nasal physiology and drug delivery

2016 · Niyanta N. Kumar, Mohan Gautam, et al. · Scientific Reports · 63

Passive Immunotherapies for Central Nervous System Disorders: Current Delivery Challenges and New Approaches

2018 · Niyanta N. Kumar, Michelle E. Pizzo, et al. · Bioconjugate Chemistry · 60

Development of Potent, Protease-Resistant Agonists of the Parathyroid Hormone Receptor with Broad β Residue Distribution

2017 · Ross W. Cheloha, Bingming Chen, et al. · Journal of Medicinal Chemistry · 25

Microglial roles in Alzheimer's disease: An agent‐based model to elucidate microglial spatiotemporal response to beta‐amyloid

2023 · Catherine Weathered, Sophia Bardehle, et al. · CPT Pharmacometrics & Systems Pharmacology · 8

Intranasal Drug Delivery to the Brain

2022 · Jeffrey J. Lochhead, Niyanta N. Kumar, et al. · AAPS advances in the pharmaceutical sciences series · 8

PBPK Modeling to Predict Clinical Drug–Drug Interaction and Impact of Hepatic Impairment for an ADC With the Payload Auristatin F‐Hydroxypropylamide

2025 · Niyanta Kumar, Vaishali Dixit, et al. · CPT Pharmacometrics & Systems Pharmacology · 5

Abstract 5810: The impact of scaffold, linker, homogeneity and payload selection on the efficacy and tolerability of anti-tubulin ADCs

2024 · Scott D. Collins, Natalie Keirstead, et al. · Cancer Research · 2

A Light sheet fluorescence microscopy and machine learning-based approach to investigate drug and biomarker distribution in whole organs and tumors

2023 · Niyanta Kumar, Petr Hrobař, et al. · bioRxiv (Cold Spring Harbor Laboratory) · 2

High-Resolution Ex Vivo Tissue Clearing, Lightsheet Imaging, and Data Analysis to Support Macromolecular Drug and Biomarker Distribution in Whole Organs and Tumors

2022 · Niyanta Kumar, Petr Hrobař, et al. · Microscopy and Microanalysis · 1

Intranasal delivery of antibodies bypasses the blood‐brain barrier and results in significantly higher central nervous system levels than systemic administration

2018 · Sam Boroumand, Niyanta Kumar, et al. · The FASEB Journal · 1

3D multiplex visualization of biologic distribution in intact tumors and organs using light-sheet microscopy

2022 · Niyanta Kumar

Multiplex Fluorescence Microscopy Platform for High-resolution ex Vivo and in Vitro imaging to Support Correlative Tissue Distribution and Biomarker Analysis

2020 · Niyanta Kumar, Mark Cancilla · Microscopy and Microanalysis

B12 and the nervous system

2015 · N. Kumar · Journal of the Neurological Sciences

Works count: 15

Citation count: 547

H-index: 7

I10-index: 5